FIT Biotech Oy: FIT Biotech to receive grant funding from

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FIT Biotech Oy: FIT Biotech to receive grant funding from Tekes

FIT BIOTECH OY Company release November 7, 2016 at 15:00 EET                                            

FIT Biotech to receive grant funding from Tekes

The Finnish Funding Agency for Innovation Tekes has made a favorable funding decision on FIT Biotech Oy's application related to the project "Biomedicine manufacturing business plan elaboration". The total cost estimate of the project is approved to be EUR 200.000 of which Tekes grant  amounts to 50% or maximally EUR 100.000.

The grant is allocated for writing the business plan including internationalization strategy, funding of implementation of the plan and related market research.

The duration of the project is October 3, 2016 - October 31,2017.

The chairman of the board, Juha Vapaavuori commented: "The funding decision by Tekes enables FIT Biotech to process its biomedicine manufacturing business plan further. The company's preparedness to operate its own GMP (Good Manufacturing Practice) level production facility is one of its strategic strengths. Therefore, the funding decision is important and of strategic significance for the company."

FIT Biotech's strategy focuses on licensing its patented GTU® (Gene Transport Unit) technology to partners for medical applications, in particular for applications with high commercial potential targeted at existing large markets or markets with a need for more efficient, safer and less costly treatments.

FIT BIOTECH OY

Further information: Juha Vapaavuori Chairman of the Board of Directors FIT Biotech Oy Tel: +358 50 372 0824 E-mail: juha.vapaavuori@sitra.fi

Certified Advisor: Aalto Capital Partners Oy, Tel. +358 40 587 7000

FIT Biotech in brief FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland market maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: Nasdaq Helsinki Principal media www.fitbiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 3

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 4

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 4

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 4

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 4

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 5

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 4

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 4

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 3

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 4

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Life Sciences Legal Teams: Key Insights from Recent Study

Updated Category News Views 113

Legal Departments in Life Sciences: A Strategic Shift As the landscape within the life sciences industry continually evolves, so too are the roles and expectations of legal departments. A recent report has illuminated this transformation, showcasing how legal teams are redefining their operations to become vital business enablers rather than merely cost-bearing centers....

Continue Reading
Intapp's Upcoming Earnings: What Investors Need to Know

Updated Category News Views 132

Intapp Prepares for Earnings Announcement Intapp (NASDAQ: INTA) is gearing up to announce its quarterly earnings shortly. Investors eagerly await this pivotal moment, hoping for news that could rally the stock price and boost confidence in the company. Understanding the expectations surrounding this announcement is crucial for anyone considering investment. Estimations...

Continue Reading
Leidos Secures Major CDC Contract to Boost NHSN Operations

Updated Category News Views 75

Leidos Awarded $51 Million CDC Contract for NHSN Enhancement Leidos (NYSE:LDOS), a recognized leader on the Fortune 500 list, has secured a substantial $51 million contract from the Centers for Disease Control and Prevention (CDC). This important contract spans five years and focuses on enhancing the capabilities of the National Healthcare Safety Network (NHSN). Leidos...

Continue Reading
Hormel's Q1 2026 Results: Solid Gains or Just Spin?

Updated Category News Views 179

Hormel Foods dropped its first-quarter results for fiscal 2026 on February 17, hinting at net sales around $3 billion. This number reflects a modest 2% organic growth, adding some sparkle after a stretch of four consecutive quarters of year-over-year growth. But you know the game; traders are already raising eyebrows. What’s beneath those figures? You holding HRL...

Continue Reading
Global Renters Insurance Market Set to Double in 10 Years

Updated Category News Views 194

Exploring the Rapid Expansion of the Renters Insurance Market The global renters insurance market is thriving, underpinned by a surge in consumer awareness regarding tenant risk protection and increasing adoption of digital insurance platforms. Individuals are increasingly investing in renters insurance as it offers financial security, liability coverage, and safeguards...

Continue Reading